We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Light Therapy Helps Stroke Survivors Recover Lost Vision

By HospiMedica International staff writers
Posted on 08 Jun 2011
Light stimulation-based Vision Restoration Therapy (VRT), a noninvasive treatment course, improves the sight and overall quality of life of stroke victims. More...


The NovaVision VRT is specifically developed for patients who suffer from a visual field deficit resulting from a neurological trauma caused by either stroke or traumatic brain injury (TBI). Patients perform vision rehabilitation seated in front of a VRT medical device, ideally in a relatively dark room free of distractions. Throughout the vision rehabilitation sessions, the patient focuses on a central point displayed on the device screen and responds whenever a stimulus is seen, mostly presented along the border of the blind area. Repeated exposure to the visual stimuli over time activates neurons in the brain that work to improve your vision through a process called neuroplasticity.

The therapy lasts for six months, with patients performing twice-daily sessions six days per week, where they focus and respond to light stimuli. During each session, the light stimuli are presented in the area most likely to recover visual function, an area believed to change as therapy progresses and vision is improved. On average, an improvement of 5% in central field of vision is observed. The NovaVision VRT is a product of NovaVision (Boca Raton, FL, USA), and has been approved by the US Food and Drug Administration (FDA).

"Vision Restoration Therapy (VRT) is a noninvasive approach to 'rewire' the visual nerves, aiming the healthy neurons to perform the function of those damaged or destroyed by a stroke, resulting in a wider visual field," said Tom Bridges, NovaVision vice president of sales and marketing.

Neuroplasticity (also known as cortical remapping) refers to the ability of the brain to change as a result of one's experience, that the brain is "plastic" and "malleable." The discovery of this feature of the brain is rather modern; the previous belief amongst scientists was that the brain does not change after the critical period of infancy. The brain consists of interconnected neurons and glial cells, and learning may happen through change in the strength of the connections, by adding or removing connections, and by the formation of new cells. "Plasticity" relates to learning by adding or removing connections, or adding cells.

Related Links:

NovaVision



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.